On Tuesday, Cramer spoke with Dr. Leonard Schleifer, president and CEO of Regeneron Pharmaceuticals .
Based in Tarrytown, N.Y., Regeneron is a biopharmaceutical company that discovers, develops and commercializes pharmaceutical products for the treatment of serious medical conditions, including and especially in the area of eye care.
Cramer has long been behind the company’s stock. He first recommended REGN when it was trading at around $5 a share in spring 2005. Those who bought the stock at those levels and have held on have seen a 1,425 percent gain. But does this stock have even more room to run? Find out by watching video of Cramer’s full conversation with Dr. Leonard Schleifer.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? email@example.com
Questions, comments, suggestions for the Mad Money website? firstname.lastname@example.org